Details
NameSymbolSector
GLENMARK PHARMACEUTICALS LIMITEDGLENMARKPharmaceuticals
Open
2133
High
2133
Low
2053.7
Close
2067.8
Volume
1484724
Exchange
nse
Time
01/08
Outlook
Score:  

0.25

Rating:  

RISKY

Candlestick Pattern
Candle pattern of Glenmark Pharmaceuticals:  
Closingmarubozu
Estimated Stoploss of Glenmark Pharmaceuticals: ₹  
2133
Glenmark Pharmaceuticals has a  
Bearishℹ
 pattern. 
Glenmark Pharmaceuticals has chances of  
Continuationℹ
 of the current trend. 
Trend
Glenmark Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glenmark Pharmaceuticals is  
Upℹ
 by  

8.68

%. 
Target
Buy @ 

1174.03

Sell @ 

2322.67

Volume
The trade volumes of Glenmark Pharmaceuticals have been  
Underperformingℹ
Though the volume trend for Glenmark Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Glenmark Pharmaceuticals is  

Up

 by  

5.57

% 
Valuation
The current market price of Glenmark Pharmaceuticals is  
Overvaluedℹ
Financials
Balance
The balance sheet of Glenmark Pharmaceuticals is:  

Balanced

Income
The income of Glenmark Pharmaceuticals is  

₹ 3267cr

 and  

Profit

 is :  

₹ 4cr

(*Mar 2025)

Glenmark Pharmaceuticals Profit is down by:  

98.85

% and Income is Down by:  

4.42

% 

(*Mar 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3418cr

 and  

Profit

 is :  

₹ 348cr

(*Dec 2024)

Glenmark Pharmaceuticals Profit is down by:  

1.69

% and Income is Down by:  

1.58

% 

(*Dec 2024)

The income of Glenmark Pharmaceuticals is  

₹ 3473cr

 and  

Profit

 is :  

₹ 354cr

(*Sep 2024)

Glenmark Pharmaceuticals Profit is up by:  

4.12

% and Income is Up by:  

6.05

% 

(*Sep 2024)

Cashflow
The cash flow of Glenmark Pharmaceuticals is  
Maintainedℹ
. It is  
Downℹ
 by  

92.09

%. 

(*Mar 2025)

49.49% operatingℹ
0.12% investingℹ
47.1% financingℹ
3.29% otherℹ
By using this site you agree to the use of cookies to deliver a better site experience.